المؤلفون: M Siringo, F Larocca, A Spagnuolo, G Gentile, M Anile, D Diso, D Santini, A Gelibter

المصدر: Current Problems in Cancer: Case Reports, Vol 14, Iss , Pp 100291- (2024)

مصطلحات موضوعية: Nsclc, Alk tyrosine kinase inhibitor, Kras g12c mutation, NGS, oncogenic driver mutations, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

العلاقة: http://www.sciencedirect.com/science/article/pii/S2666621924000140Test; https://doaj.org/toc/2666-6219Test

الوصول الحر: https://doaj.org/article/30d1a6c3f25f4f92af1b5d2c31fefd6dTest

المؤلفون: Gettinger, Scott N, Huber, Rudolf M, Kim, Dong-Wan, Bazhenova, Lyudmila, Hansen, Karin Holmskov, Tiseo, Marcello, Langer, Corey J, Rodríguez, Luis G Paz-Ares, West, Howard L, Reckamp, Karen L, Weiss, Glen J, Smit, Egbert F, Hochmair, Maximilian J, Kim, Sang-We, Ahn, Myung-Ju, Kim, Edward S, Groen, Harry JM, Pye, Joanna, Liu, Yuyin, Zhang, Pingkuan, Vranceanu, Florin, Camidge, D Ross

المصدر: JTO Clinical and Research Reports. 3(9)

مصطلحات موضوعية: Biomedical and Clinical Sciences, Clinical Sciences, Oncology and Carcinogenesis, Clinical Trials and Supportive Activities, Cancer, Clinical Research, Evaluation of treatments and therapeutic interventions, 6.1 Pharmaceuticals, 6.2 Cellular and gene therapies, ALK tyrosine kinase inhibitor, Anaplastic lymphoma kinase, Brigatinib, Crizotinib, Non–small-cell lung cancer

وصف الملف: application/pdf

الوصول الحر: https://escholarship.org/uc/item/9wr5984cTest

المؤلفون: Hitoshi Ohno

المصدر: Tenri Medical Bulletin. 2023, 26(1):32

المؤلفون: Gettinger, Scott N., Huber, Rudolf M., Kim, Dong-Wan, Bazhenova, Lyudmila, Hansen, Karin Holmskov, Tiseo, Marcello, Langer, Corey J., Paz-Ares Rodríguez, Luis G., West, Howard L., Reckamp, Karen L., Weiss, Glen J., Smit, Egbert F., Hochmair, Maximilian J., Kim, Sang-We, Ahn, Myung-Ju, Kim, Edward S., Groen, Harry J.M., Pye, Joanna, Liu, Yuyin, Zhang, Pingkuan, Vranceanu, Florin, Camidge, D. Ross

المساهمون: Kim, Dong-Wan

مصطلحات موضوعية: ALK tyrosine kinase inhibitor, Anaplastic lymphoma kinase, Brigatinib, Crizotinib, Non–small-cell lung cancer

العلاقة: JTO Clinical and Research Reports, Vol.3 No.9, p. 100385; https://hdl.handle.net/10371/192475Test; 2-s2.0-85136559895; 183806

الإتاحة: https://doi.org/10.1016/j.jtocrr.2022.100385Test
https://hdl.handle.net/10371/192475Test

المؤلفون: Scott N. Gettinger, MD, Rudolf M. Huber, MD, PhD, Dong-Wan Kim, MD, PhD, Lyudmila Bazhenova, MD, Karin Holmskov Hansen, MD, Marcello Tiseo, MD, Corey J. Langer, MD, FACP, Luis G. Paz-Ares Rodríguez, MD, PhD, Howard L. West, MD, Karen L. Reckamp, MD, MS, Glen J. Weiss, MD, Egbert F. Smit, MD, PhD, Maximilian J. Hochmair, MD, Sang-We Kim, MD, PhD, Myung-Ju Ahn, MD, PhD, Edward S. Kim, MD, FACP, Harry J.M. Groen, MD, PhD, Joanna Pye, MS, Yuyin Liu, PhD, Pingkuan Zhang, MD, Florin Vranceanu, MD, PhD, D. Ross Camidge, MD, PhD

المصدر: JTO Clinical and Research Reports, Vol 3, Iss 9, Pp 100385- (2022)

مصطلحات موضوعية: Anaplastic lymphoma kinase, ALK tyrosine kinase inhibitor, Brigatinib, Crizotinib, Non–small-cell lung cancer, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

العلاقة: http://www.sciencedirect.com/science/article/pii/S2666364322001096Test; https://doaj.org/toc/2666-3643Test

الوصول الحر: https://doaj.org/article/78d40f5a880944a8b24323de142222e5Test

المؤلفون: Hidetoshi Satomi, Hiroshi Kuraishi, Ichiro Ito, Isano Hase, Manabu Yamamoto, Ryota Ozawa, Shigeru Koyama, Shunnosuke Tanaka, Takeshi Masubuchi, Yuki Takeuchi, 伊藤 以知郎, 倉石 博, 増渕 雄, 小山 茂, 小澤 亮太, 山本 学, 武内 裕希, 田中 駿ノ介, 里見 英俊, 長谷 衣佐乃

المصدر: 肺癌 / Haigan. 2022, 62(7):1001

المؤلفون: Gettinger, Scott N., Huber, Rudolf M., Kim, Dong Wan, Bazhenova, Lyudmila, Hansen, Karin Holmskov, Tiseo, Marcello, Langer, Corey J., Paz-Ares Rodríguez, Luis G., West, Howard L., Reckamp, Karen L., Weiss, Glen J., Smit, Egbert F., Hochmair, Maximilian J., Kim, Sang We, Ahn, Myung Ju, Kim, Edward S., Groen, Harry J.M., Pye, Joanna, Liu, Yuyin, Zhang, Pingkuan, Vranceanu, Florin, Camidge, D. Ross

المصدر: Gettinger , S N , Huber , R M , Kim , D W , Bazhenova , L , Hansen , K H , Tiseo , M , Langer , C J , Paz-Ares Rodríguez , L G , West , H L , Reckamp , K L , Weiss , G J , Smit , E F , Hochmair , M J , Kim , S W , Ahn , M J , Kim , E S , Groen , H J M , Pye , J , Liu , Y , Zhang , P , Vranceanu , ....

مصطلحات موضوعية: ALK tyrosine kinase inhibitor, Anaplastic lymphoma kinase, Brigatinib, Crizotinib, Non–small-cell lung cancer

وصف الملف: application/pdf

العلاقة: https://research.rug.nl/en/publications/c50d84cd-1e02-472b-88f8-c3f12743c7d7Test

الإتاحة: https://doi.org/10.1016/j.jtocrr.2022.100385Test
https://hdl.handle.net/11370/c50d84cd-1e02-472b-88f8-c3f12743c7d7Test
https://research.rug.nl/en/publications/c50d84cd-1e02-472b-88f8-c3f12743c7d7Test
https://pure.rug.nl/ws/files/238313317/1_s2.0_S2666364322001096_main.pdfTest

المساهمون: D Ross Camidge, Hye Ryun Kim, Myung-Ju Ahn, James C H Yang, Ji-Youn Han, Maximilian J Hochmair, Ki Hyeong Lee, Angelo Delmonte, Maria Rosario Garcia Campelo, Dong-Wan Kim, Frank Griesinger, Enriqueta Felip, Raffaele Califano, Alexander I Spira, Scott N Gettinger, Marcello Tiseo, Huamao M Lin, Yuyin Liu, Florin Vranceanu, Huifeng Niu, Pingkuan Zhang, Sanjay Popat, Kim, Hye Ryun

مصطلحات موضوعية: Anaplastic Lymphoma Kinase / genetics, Crizotinib / therapeutic use, Humans, Lung Neoplasms* / drug therapy, Lung Neoplasms* / genetics, Organophosphorus Compounds, Protein Kinase Inhibitors / therapeutic use, Pyrimidines / therapeutic use, ALK tyrosine kinase inhibitor, Anaplastic lymphoma kinase, Brigatinib, Crizotinib, Non–small cell lung cancer

العلاقة: JOURNAL OF THORACIC ONCOLOGY; J01909; OAK-2022-04520; https://ir.ymlib.yonsei.ac.kr/handle/22282913/190628Test; T202126214; JOURNAL OF THORACIC ONCOLOGY, Vol.16(12) : 2091-2108, 2021-12

الإتاحة: https://doi.org/10.1016/j.jtho.2021.07.035Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/190628Test

المؤلفون: Camidge D. R., Kim H. R., Ahn M. -J., Yang J. C. H., Han J. -Y., Hochmair M. J., Lee K. H., Delmonte A., Garcia Campelo M. R., Kim D. -W., Griesinger F., Felip E., Califano R., Spira A. I., Gettinger S. N., Tiseo M., Lin H. M., Liu Y., Vranceanu F., Niu H., Zhang P., Popat S.

المساهمون: Camidge, D. R., Kim, H. R., Ahn, M. -J., Yang, J. C. H., Han, J. -Y., Hochmair, M. J., Lee, K. H., Delmonte, A., Garcia Campelo, M. R., Kim, D. -W., Griesinger, F., Felip, E., Califano, R., Spira, A. I., Gettinger, S. N., Tiseo, M., Lin, H. M., Liu, Y., Vranceanu, F., Niu, H., Zhang, P., Popat, S.

مصطلحات موضوعية: ALK tyrosine kinase inhibitor, Anaplastic lymphoma kinase, Brigatinib, Crizotinib, Non–small cell lung cancer

العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000721176100017; volume:16; issue:12; firstpage:2091; lastpage:2108; numberofpages:18; journal:JOURNAL OF THORACIC ONCOLOGY; http://hdl.handle.net/11381/2901090Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85116813235

الإتاحة: https://doi.org/10.1016/j.jtho.2021.07.035Test
http://hdl.handle.net/11381/2901090Test

المؤلفون: Maximilian J. Hochmair, Hannah Fabikan, Oliver Illini, Christoph Weinlinger, Ulrike Setinek, Dagmar Krenbek, Helmut Prosch, Markus Rauter, Michael Schumacher, Ewald Wöll, Romana Wass, Elmar Brehm, Gudrun Absenger, Tatjana Bundalo, Peter Errhalt, Matthias Urban, Arschang Valipour

المصدر: Pharmaceuticals; Volume 13; Issue 11; Pages: 371

مصطلحات موضوعية: ALK -positive disease, ROS1 -positive disease, ALK tyrosine kinase inhibitor treatment, sequential treatment, lorlatinib

وصف الملف: application/pdf

العلاقة: Pharmacology; https://dx.doi.org/10.3390/ph13110371Test

الإتاحة: https://doi.org/10.3390/ph13110371Test